| Diego(a)-Cyte 3%
80134860316 |
Immunohematology - rare antisera for conventional methods |
III |
GRIFOLS BRASIL LTDA |
30/06/2025 |
Until 30/06/2035 |
| Grifols sCD38
80134860308 |
Anti-daratumumab antibody |
II |
GRIFOLS BRASIL LTDA |
17/02/2025 |
Valid |
| Anti-C3d
80134860302 |
Anti-human globulin (Coombs) |
III |
GRIFOLS BRASIL LTDA |
11/12/2023 |
Until 11/12/2033 |
| Anti-IgG
80134860303 |
Anti-human globulin (Coombs) |
III |
GRIFOLS BRASIL LTDA |
11/12/2023 |
Until 11/12/2033 |
| Coombs Control
80134860301 |
Anti-human globulin (Coombs) |
III |
GRIFOLS BRASIL LTDA |
04/12/2023 |
Until 04/12/2033 |
| Screen-Cyte Dia 3%
80134860297 |
Immunohematology - red cell reagents/enzyme-treated red cells |
III |
GRIFOLS BRASIL LTDA |
23/10/2023 |
Until 23/10/2033 |
| Sero-Cyte 3%
80134860299 |
Immunohematology - red cell reagents/enzyme-treated red cells |
III |
GRIFOLS BRASIL LTDA |
23/10/2023 |
Until 23/10/2033 |
| Data-Cyte Plus 3%
80134860300 |
Immunohematology - red cell reagents/enzyme-treated red cells |
III |
GRIFOLS BRASIL LTDA |
23/10/2023 |
Until 23/10/2033 |
| Anti-Human Globulin Mono-Type (green)
80134860296 |
Anti-human globulin (Coombs) |
III |
GRIFOLS BRASIL LTDA |
02/10/2023 |
Until 02/10/2033 |
| Sero-Cyte Pool Diª 0.8%
80134860291 |
Immunohematology - red cell reagents/enzyme-treated red cells |
III |
GRIFOLS BRASIL LTDA |
26/06/2023 |
Until 26/06/2033 |
| Anti-Fyb Mono-Type Dual
80134860292 |
Immunohematology - Rh-hr, Kell, Kidd, Duffy - human source |
IV |
GRIFOLS BRASIL LTDA |
26/06/2023 |
Until 26/06/2033 |
| Specific Albumin 22%
80134860286 |
Buffers, diluents and other solutions for laboratory analysis |
I |
GRIFOLS BRASIL LTDA |
06/03/2023 |
Valid |
| Enlisst-II
80134860287 |
Buffers, diluents and other solutions for laboratory analysis |
I |
GRIFOLS BRASIL LTDA |
06/03/2023 |
Valid |
| Data-Cyte Extend 0.8%
80134860284 |
Immunohematology - red cell reagents/enzyme-treated red cells |
III |
GRIFOLS BRASIL LTDA |
08/08/2022 |
Until 08/08/2032 |
| Diego(a)-Cyte 0.8%
80134860280 |
Immunohematology - red cell reagents/enzyme-treated red cells |
III |
GRIFOLS BRASIL LTDA |
06/09/2021 |
Until 06/09/2031 |
| Data-Cyte Plus P 0.8%
80134860279 |
Immunohematology - red cell reagents/enzyme-treated red cells |
III |
GRIFOLS BRASIL LTDA |
30/08/2021 |
Until 30/08/2031 |
| Screen-Cyte P 0.8%
80134860274 |
Immunohematology - red cell reagents/enzyme-treated red cells |
III |
GRIFOLS BRASIL LTDA |
22/03/2021 |
Until 22/03/2031 |
| Família Reverse-Cyte® 5%
80134860273 |
Multiple blood grouping ABO - human origin |
IV |
GRIFOLS BRASIL LTDA |
28/12/2020 |
Until 28/12/2030 |
| Família Anti-Lea for DG Gel e Anti-Leb for DG Gel
80134860272 |
Immunohematology - rare antisera for column technology |
III |
GRIFOLS BRASIL LTDA |
15/06/2020 |
Until 15/06/2030 |
| Anti-Lua for DG Gel
80134860271 |
Immunohematology - rare antisera for conventional methods |
III |
GRIFOLS BRASIL LTDA |
02/12/2019 |
Until 02/12/2029 |
| Anti-Cw Mono-Type Dual
80134860268 |
Immunohematology - ABO - monoclonal source |
IV |
GRIFOLS BRASIL LTDA |
25/11/2019 |
Until 25/11/2029 |
| Reverse-Cyte 0.8%
80134860269 |
Multiple blood grouping ABO - human origin |
IV |
GRIFOLS BRASIL LTDA |
25/11/2019 |
Until 25/11/2029 |
| Anti-Lub Mono-Type Dual
80134860270 |
Immunohematology - rare antisera for conventional methods |
III |
GRIFOLS BRASIL LTDA |
25/11/2019 |
Until 25/11/2029 |
| Anti-M Mono-Type Dual e Anti-N (LN3/MN879) Mono-Type
80134860264 |
Immunohematology - rare antisera for conventional methods |
III |
GRIFOLS BRASIL LTDA |
02/09/2019 |
Until 02/09/2029 |
| Anti-S Mono-Type e Anti-s Mono-Type
80134860265 |
Immunohematology - rare antisera for conventional methods |
III |
GRIFOLS BRASIL LTDA |
02/09/2019 |
Until 02/09/2029 |
| Família Anti-Kpa Dual e Anti-Kpb Dual
80134860261 |
Immunohematology - Rh-hr, Kell, Kidd, Duffy - monoclonal source |
IV |
GRIFOLS BRASIL LTDA |
03/06/2019 |
Until 03/06/2029 |
| Anti-P1 Mono-Type Dual
80134860262 |
Immunohematology - rare antisera for conventional methods |
III |
GRIFOLS BRASIL LTDA |
03/06/2019 |
Until 03/06/2029 |
| Bromelase® 30
80134860260 |
Buffers, diluents and other solutions for laboratory analysis |
I |
GRIFOLS BRASIL LTDA |
15/04/2019 |
Valid |
| Anti-K Mono-Type (2)
80134860251 |
Immunohematology - Rh-hr, Kell, Kidd, Duffy - monoclonal source |
IV |
GRIFOLS BRASIL LTDA |
26/02/2018 |
Until 26/02/2028 |
| Data-Cyte® Plus 0.8%
80134860250 |
Immunohematology - red cell reagents/enzyme-treated red cells |
III |
GRIFOLS BRASIL LTDA |
17/07/2017 |
Until 17/07/2027 |
| Anti-K (Cellano) Mono-Type
80134860243 |
Immunohematology - Rh-hr, Kell, Kidd, Duffy - monoclonal source |
IV |
GRIFOLS BRASIL LTDA |
10/07/2017 |
Until 10/07/2027 |
| Anti-Fya Mono-Type
80134860244 |
Immunohematology - Rh-hr, Kell, Kidd, Duffy - monoclonal source |
IV |
GRIFOLS BRASIL LTDA |
10/07/2017 |
Until 10/07/2027 |
| Anti-H Mono-Type
80134860245 |
Immunohematology - Rh-hr, Kell, Kidd, Duffy - monoclonal source |
IV |
GRIFOLS BRASIL LTDA |
10/07/2017 |
Until 10/07/2027 |
| Anti-D IgG Mono-Type
80134860246 |
Immunohematology - Rh-hr, Kell, Kidd, Duffy - monoclonal source |
IV |
GRIFOLS BRASIL LTDA |
10/07/2017 |
Until 10/07/2027 |
| Anti-A1 Lectin
80134860248 |
Immunohematology - lectins |
III |
GRIFOLS BRASIL LTDA |
10/07/2017 |
Until 10/07/2027 |
| Anti-Fya for DG Gel e Anti-Fyb for DG Gel
80134860249 |
Immunohematology - Rh-hr, Kell, Kidd, Duffy - human source |
IV |
GRIFOLS BRASIL LTDA |
10/07/2017 |
Until 10/07/2027 |
| Anti-Dia Dual
80134860234 |
Immunohematology - rare antisera for conventional methods |
III |
GRIFOLS BRASIL LTDA |
19/06/2017 |
Until 19/06/2027 |
| Extended IV Control
80134860213 |
Combined parameters in one product - class IV |
IV |
GRIFOLS BRASIL LTDA |
03/11/2015 |
Until 03/11/2035 |
| Essential II Control
80134860214 |
Combined parameters in one product - class IV |
IV |
GRIFOLS BRASIL LTDA |
03/11/2015 |
Until 03/11/2035 |
| Sero-Cyte Pool 0,8%
80134860209 |
Immunohematology - red cell reagents/enzyme-treated red cells |
III |
GRIFOLS BRASIL LTDA |
29/06/2015 |
Until 29/06/2035 |
| ANTI-SOROS DE FENÓTIPO EXTENDIDO
80134860200 |
Immunohematology - rare antisera for conventional methods |
III |
GRIFOLS BRASIL LTDA |
27/04/2015 |
Until 27/04/2035 |